These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21190302)

  • 1. The prostaglandin E(2) system: a toolbox for skeletal repair?
    Gelse K; Beyer C
    Arthritis Rheum; 2011 Apr; 63(4):871-3. PubMed ID: 21190302
    [No Abstract]   [Full Text] [Related]  

  • 2. Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice.
    Kamolratanakul P; Hayata T; Ezura Y; Kawamata A; Hayashi C; Yamamoto Y; Hemmi H; Nagao M; Hanyu R; Notomi T; Nakamoto T; Amagasa T; Akiyoshi K; Noda M
    Arthritis Rheum; 2011 Apr; 63(4):1021-33. PubMed ID: 21190246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of prostaglandin E2 in bone].
    Oida H; Oda K; Maruyama T
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():120-4. PubMed ID: 15035109
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostaglandin E(2) receptors in bone formation.
    Li M; Thompson DD; Paralkar VM
    Int Orthop; 2007 Dec; 31(6):767-72. PubMed ID: 17593365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanogel-based delivery system enhances PGE2 effects on bone formation.
    Kato N; Hasegawa U; Morimoto N; Saita Y; Nakashima K; Ezura Y; Kurosawa H; Akiyoshi K; Noda M
    J Cell Biochem; 2007 Aug; 101(5):1063-70. PubMed ID: 17520665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prostanoid receptor EP4 agonist enhances ectopic bone formation induced by recombinant human bone morphogenetic protein-2.
    Sasaoka R; Terai H; Toyoda H; Imai Y; Sugama R; Takaoka K
    Biochem Biophys Res Commun; 2004 Jun; 318(3):704-9. PubMed ID: 15144895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoblastic bone formation is induced by using nanogel-crosslinking hydrogel as novel scaffold for bone growth factor.
    Hayashi C; Hasegawa U; Saita Y; Hemmi H; Hayata T; Nakashima K; Ezura Y; Amagasa T; Akiyoshi K; Noda M
    J Cell Physiol; 2009 Jul; 220(1):1-7. PubMed ID: 19301257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactive Molecule-loaded Drug Delivery Systems to Optimize Bone Tissue Repair.
    Oshiro JA; Sato MR; Scardueli CR; Lopes de Oliveira GJP; Abucafy MP; Chorilli M
    Curr Protein Pept Sci; 2017; 18(8):850-863. PubMed ID: 28355998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of prostaglandin E2 receptor subtype 4 agonist and sulfasalazine in mouse colitis prevention and treatment.
    Jiang GL; Im WB; Donde Y; Wheeler LA
    J Pharmacol Exp Ther; 2010 Dec; 335(3):546-52. PubMed ID: 20833794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostaglandins in bone: bad cop, good cop?
    Blackwell KA; Raisz LG; Pilbeam CC
    Trends Endocrinol Metab; 2010 May; 21(5):294-301. PubMed ID: 20079660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of basic fibroblast growth factor and a prostaglandin E2 receptor subtype 4 agonist on osteoblastogenesis and adipogenesis in aged ovariectomized rats.
    Aguirre JI; Leal ME; Rivera MF; Vanegas SM; Jorgensen M; Wronski TJ
    J Bone Miner Res; 2007 Jun; 22(6):877-88. PubMed ID: 17352655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2-dependent prostaglandin E2 down-regulates intercellular adhesion molecule-1 expression via EP2/EP4 receptors in interleukin-1beta-stimulated human gingival fibroblasts.
    Noguchi K; Iwasaki K; Shitashige M; Endo H; Kondo H; Ishikawa I
    J Dent Res; 2000 Dec; 79(12):1955-61. PubMed ID: 11201045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
    Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
    J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of acute rejection by administration of prostaglandin E2 receptor subtype 4 agonist in rat organ transplantation models.
    Okamoto T; Okamoto S; Fujimoto Y; Tabata Y; Uemoto S
    J Surg Res; 2013 Aug; 183(2):852-9. PubMed ID: 23478083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of rhBMP-2 dose on bone formation/maturation in a rat critical-size calvarial defect model.
    Pelaez M; Susin C; Lee J; Fiorini T; Bisch FC; Dixon DR; McPherson JC; Buxton AN; Wikesjö UM
    J Clin Periodontol; 2014 Aug; 41(8):827-36. PubMed ID: 24807100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut.
    Kabashima K; Saji T; Murata T; Nagamachi M; Matsuoka T; Segi E; Tsuboi K; Sugimoto Y; Kobayashi T; Miyachi Y; Ichikawa A; Narumiya S
    J Clin Invest; 2002 Apr; 109(7):883-93. PubMed ID: 11927615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biologic augmentation of polymer scaffolds for bone repair.
    Guldberg RE; Oest ME; Dupont K; Peister A; Deutsch E; Kolambkar Y; Mooney D
    J Musculoskelet Neuronal Interact; 2007; 7(4):333-4. PubMed ID: 18094499
    [No Abstract]   [Full Text] [Related]  

  • 18. Prostaglandin E2 inhibits elastogenesis in the ductus arteriosus via EP4 signaling.
    Yokoyama U; Minamisawa S; Shioda A; Ishiwata R; Jin MH; Masuda M; Asou T; Sugimoto Y; Aoki H; Nakamura T; Ishikawa Y
    Circulation; 2014 Jan; 129(4):487-96. PubMed ID: 24146253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of rhBMP-2 and natural latex as potential osteogenic proteins in critical size defects by histomorphometric methods.
    Issa JP; Defino HL; Netto JC; Volpon JB; Regalo SC; Iyomasa MM; Siéssere S; Tiossi R
    Anat Rec (Hoboken); 2010 May; 293(5):794-801. PubMed ID: 20225196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitory effect of prostaglandin E(2) on the migration of nasal fibroblasts.
    Shin JM; Park IH; Moon YM; Hong SM; Cho JS; Um JY; Lee HM
    Am J Rhinol Allergy; 2014; 28(3):e120-4. PubMed ID: 24980222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.